Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise | Markets Insider
Teva Pharma CEO Richard Francis on Q4 earnings
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? | InvestorPlace
Amid US drug shortages, Teva plots cuts to its generics portfolio
Teva shares surge after announcing global opioid settlement
Teva expected to report higher Q3 earnings, revenue early Wednesday (TEVA) | Seeking Alpha
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceutical Industries says it'll close Bucks Co. plant in 2017 | Business News | wfmz.com
Teva weighs potential sale of its $2B API business: reports
Teva Pharma News, Teva Pharma Quote, TEVA Quote - StreetInsider.com
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis - Boston News, Weather, Sports | WHDH 7News
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva Pharma sees lower 2024 profit but higher sales after large Q4 beat | Reuters
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Opioid Lawsuit Against Teva Pharma
